Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
50%(4 trials)

Phase Distribution

Ph phase_1
4
50%
Ph phase_2
4
50%

Phase Distribution

4

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
4(50.0%)
Phase 2Efficacy & side effects
4(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (50.0%)
Phase 24 (50.0%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

TLESR-impedance Study in Patients

NCT00743444
completedphase_2

Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

NCT00394472
completedphase_2

Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

NCT00703534
completedphase_2

A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience

NCT01043185
completedphase_1

Renal Impairment Study

NCT00863161
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00743444Phase 2

TLESR-impedance Study in Patients

Completed
NCT00394472Phase 2

Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

Completed
NCT00703534Phase 2

Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

Completed
NCT01043185Phase 2

A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience

Completed
NCT00863161Phase 1

Renal Impairment Study

Completed
NCT00757419Phase 1

AZD3355 Dose-escalation Study in Healthy Males

Completed
NCT00688402Phase 1

Study to Compare Different Formulations of AZD3355

Completed
NCT00684190Phase 1

Drug Interaction Study Between AZD3355 and Nexium

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8